Ascent Group LLC Has $1.36 Million Stock Position in Colgate-Palmolive (NYSE:CL)

Ascent Group LLC grew its position in Colgate-Palmolive (NYSE:CL) by 10.1% in the 2nd quarter, according to its most recent filing with the SEC. The firm owned 14,022 shares of the company’s stock after buying an additional 1,289 shares during the period. Ascent Group LLC’s holdings in Colgate-Palmolive were worth $1,361,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently made changes to their positions in CL. Driehaus Capital Management LLC increased its holdings in Colgate-Palmolive by 63.9% in the second quarter. Driehaus Capital Management LLC now owns 12,294 shares of the company’s stock valued at $1,193,000 after purchasing an additional 4,792 shares during the last quarter. Kathmere Capital Management LLC increased its holdings in Colgate-Palmolive by 23.7% in the second quarter. Kathmere Capital Management LLC now owns 11,804 shares of the company’s stock valued at $1,145,000 after purchasing an additional 2,265 shares during the last quarter. Susquehanna Fundamental Investments LLC bought a new stake in Colgate-Palmolive in the second quarter valued at about $2,125,000. Security National Bank of SO Dak increased its holdings in Colgate-Palmolive by 1.4% in the second quarter. Security National Bank of SO Dak now owns 25,347 shares of the company’s stock valued at $2,460,000 after purchasing an additional 355 shares during the last quarter. Finally, Legal & General Group Plc increased its holdings in Colgate-Palmolive by 0.8% in the second quarter. Legal & General Group Plc now owns 7,785,101 shares of the company’s stock valued at $755,465,000 after purchasing an additional 61,413 shares during the last quarter. 80.41% of the stock is owned by institutional investors and hedge funds.

Colgate-Palmolive Price Performance

Colgate-Palmolive stock opened at $103.80 on Tuesday. The stock’s fifty day moving average price is $103.37 and its two-hundred day moving average price is $96.53. Colgate-Palmolive has a one year low of $67.62 and a one year high of $109.30. The company has a debt-to-equity ratio of 16.90, a current ratio of 1.06 and a quick ratio of 0.70. The firm has a market cap of $85.16 billion, a PE ratio of 32.85, a price-to-earnings-growth ratio of 3.62 and a beta of 0.40.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, July 26th. The company reported $0.91 EPS for the quarter, topping analysts’ consensus estimates of $0.87 by $0.04. Colgate-Palmolive had a return on equity of 470.19% and a net margin of 14.21%. The firm had revenue of $5.06 billion for the quarter, compared to analyst estimates of $5 billion. During the same quarter last year, the company earned $0.77 EPS. The company’s revenue was up 4.9% on a year-over-year basis. As a group, research analysts expect that Colgate-Palmolive will post 3.57 EPS for the current fiscal year.

Colgate-Palmolive Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be issued a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.93%. The ex-dividend date of this dividend is Friday, October 18th. Colgate-Palmolive’s dividend payout ratio is presently 63.29%.

Insider Buying and Selling at Colgate-Palmolive

In other Colgate-Palmolive news, insider Sally Massey sold 15,850 shares of the firm’s stock in a transaction on Tuesday, August 6th. The stock was sold at an average price of $103.28, for a total value of $1,636,988.00. Following the sale, the insider now owns 13,942 shares of the company’s stock, valued at approximately $1,439,929.76. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. In other Colgate-Palmolive news, insider Sally Massey sold 15,850 shares of the firm’s stock in a transaction on Tuesday, August 6th. The stock was sold at an average price of $103.28, for a total value of $1,636,988.00. Following the sale, the insider now owns 13,942 shares of the company’s stock, valued at approximately $1,439,929.76. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider Panagiotis Tsourapas sold 14,794 shares of the firm’s stock in a transaction on Thursday, August 8th. The shares were sold at an average price of $102.94, for a total value of $1,522,894.36. Following the completion of the sale, the insider now directly owns 5,146 shares in the company, valued at approximately $529,729.24. The disclosure for this sale can be found here. In the last quarter, insiders have sold 43,490 shares of company stock valued at $4,486,063. 0.34% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

A number of research firms recently commented on CL. Redburn Atlantic upgraded Colgate-Palmolive to a “hold” rating in a report on Thursday, August 1st. Bank of America increased their price target on Colgate-Palmolive from $100.00 to $110.00 and gave the stock a “buy” rating in a report on Wednesday, July 10th. HSBC restated a “hold” rating on shares of Colgate-Palmolive in a report on Friday, July 26th. Citigroup increased their price target on Colgate-Palmolive from $103.00 to $112.00 and gave the stock a “buy” rating in a report on Wednesday, July 10th. Finally, TD Cowen increased their price target on Colgate-Palmolive from $110.00 to $115.00 and gave the stock a “buy” rating in a report on Tuesday, July 30th. One research analyst has rated the stock with a sell rating, eight have assigned a hold rating and fourteen have issued a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $104.74.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.